Literature DB >> 7258184

Factor VII deficiency.

M V Ragni, J H Lewis, J A Spero, U Hasiba.   

Abstract

This report describes three patients with factor (F) VII deficiency: two adult siblings and an unrelated 5 1/2-month-old child who succumbed after several central nervous system (CNS) hemorrhages. This event prompted a review of the literature concerning the incidence and characteristics of intracranial hemorrhage in congenital F VII deficiency. Of 138 patients reported to have F VII deficiency, only 75 were considered to have a true deficiency. There was a 1:1 sex distribution with a 19% incidence of consanguinity in the 63 families which these 75 patients represented. CNS hemorrhage occurred in 12 of the 75 proven factor-deficient patients -- an incidence of 16.0%. There was a 1.4:1 female predominance in this group with a 44.4% incidence of consanguinity in their nine families. Except for one patient with hypertension, there was no history of preceding trauma or previous underlying CNS abnormality, though head trauma with a difficult vaginal delivery may have occurred in five infants. Diagnostic lumbar puncture or ventricular tap revealed bloody, xanthochromic cerebrospinal fluid in five. Five patients with F VII deficiency developed a CNS hemorrhage prior to 1 week of age, and none survived. Seven patients older than 1 week of age suffered such an event, and four of these survived. It is concluded that the greatest risk factor for development of CNS hemorrhage is trauma related to the birth process.

Entities:  

Mesh:

Year:  1981        PMID: 7258184     DOI: 10.1002/ajh.2830100112

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays.

Authors:  T Takase; E G Tuddenham; S Chand; A H Goodall
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

2.  Factor V deficiency and antenatal intraventricular haemorrhage.

Authors:  A Whitelaw; M E Haines; W Bolsover; E Harris
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

3.  Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.

Authors:  E K Spicer; R Horton; L Bloem; R Bach; K R Williams; A Guha; J Kraus; T C Lin; Y Nemerson; W H Konigsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Canine specific ELISA for coagulation factor VII.

Authors:  Tom Knudsen; Mads Kjelgaard-Hansen; Mikael Tranholm; Bo Wiinberg; Jes T Clausen; Jens Jacob Hansen; Timothy C Nichols; Marianne Kjalke; Asger L Jensen; Annemarie T Kristensen
Journal:  Vet J       Date:  2011-01-08       Impact factor: 2.688

5.  Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.

Authors:  J C Chan; P Carmeliet; L Moons; E D Rosen; Z F Huang; G J Broze; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).

Authors:  Mariasanta Napolitano; Muriel Giansily-Blaizot; Alberto Dolce; Jean F Schved; Guenter Auerswald; Jørgen Ingerslev; Jens Bjerre; Carmen Altisent; Pimlak Charoenkwan; Lisa Michaels; Ampaiwan Chuansumrit; Giovanni Di Minno; Umran Caliskan; Guglielmo Mariani
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

7.  Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.

Authors:  G J Broze; S Hickman; J P Miletich
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 8.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.

Authors:  A Girolami; F Tezza; R Scandellari; S Vettore; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 9.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

Review 10.  Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders.

Authors:  Giancarlo Castaman; Silvia Linari
Journal:  J Clin Med       Date:  2017-04-10       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.